Streetbeat News

Stock Prices

CARG

CARS

CVNA

KMX

TRUE

VRM

Carvana Co (NYSE:CVNA) is set to report Q3 earnings on Nov. 2, with expectations of a negative 80 cents in EPS and $2.78 billion in revenues. The company's stock has seen significant fluctuations, with a boost following a successful debt restructuring agreement that reduced total debt by over $1.2 billion. However, analysts have expressed concerns about the higher interest rates on all of its debt as a result of the restructuring. The stock is currently rated as 'Hold' with a consensus price target of $28.68.

Portfolio Pulse from Surbhi Jain

November 02, 2023 | 1:17 pm

IONM

Assure Holdings Corp. (NASDAQ:IONM), a provider of intraoperative neuromonitoring and remote neurology services, has been granted an extension by Nasdaq to regain compliance with the stockholders' equity continued listing requirement. The company has until January 22, 2024, to complete key steps of its compliance plan and must demonstrate compliance upon filing its periodic report for the quarter ended March 31, 2024. Failure to comply may result in delisting.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 1:14 pm

JEWL

Adamas One Corp. (Nasdaq: JEWL) has announced the initial delivery of high-quality, single-crystal, lab-grown colorless diamonds. The company's R&D efforts have led to the creation of D, E, and F diamonds, which are considered colorless. CEO Jay Grdina believes their proprietary machinery and processes give them a competitive advantage in the jewelry, tech, and industrial sectors. The company plans to expand production as lab-grown diamonds now represent over 50% of diamond sales in the US.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 1:14 pm

RACE

Ferrari reported its Q3 financial results, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 1:09 pm

LLY

NVO

WW International Inc (NASDAQ:WW), formerly known as Weight Watchers, is set to report its Q3 earnings on Nov. 2. The company has been struggling with falling revenues and a large debt pile of $1.4 billion. The recent $132 million acquisition of Sequence Health is expected to provide new subscribers access to weight-loss drugs such as Ozempic, Wegovy, Mounjaro, and Trulicity. The stock is down about 30% over the past month.

Portfolio Pulse from Surbhi Jain

November 02, 2023 | 1:09 pm

AAPL

AMD

NVDA

PLTR

PYPL

QQQ

ROKU

SBUX

TSLA

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 1:08 pm

PYPL

PayPal's shares are trading higher following the release of its Q3 financial results, which exceeded expectations. The company also issued guidance.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 1:08 pm

NKLA

Nikola Corporation's Q3 2023 report shows a significant decrease in shipped trucks, with only 3 units shipped compared to 63 units in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 1:06 pm

CROX

JAKK

RCKY

WAFU

Several consumer discretionary stocks showed significant movement in Thursday's pre-market session. Jakks Pacific, Rocky Brands, DoorDash, Starbucks, Camping World Holdings, and Modine Manufacturing all saw increases, with Q3 earnings reports being a common factor. Conversely, Crocs, Wah Fu Education Group, Kidpik, Sturm Ruger & Co, Marriott Vacations, and Kontoor Brands all experienced decreases, with Q3 earnings also playing a role.

Portfolio Pulse from Benzinga Insights

November 02, 2023 | 1:06 pm

CLLS

DRIO

MRNA

PBLA

In Thursday's pre-market session, several healthcare stocks saw significant movement. Panbela Therapeutics, Cellectis, CareDx, Avenue Therapeutics, Genprex, and Akanda saw gains, while Outlook Therapeutics, DarioHealth, Acurx Pharmaceuticals, Moderna, Sonendo, and Envista Holdings experienced losses. Q3 earnings reports for DarioHealth, Moderna, and Envista Holdings were released recently.

Portfolio Pulse from Benzinga Insights

November 02, 2023 | 1:06 pm